Cornell Pochily Investment Advisors, Inc. Biogen Inc. Transaction History

Cornell Pochily Investment Advisors, Inc.

$262 Million
Q2 2024

A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 1,366 shares of BIIB stock, worth $252,409. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,366

Previous 1,441 5.2%

Holding current value

$252,409

Previous $310,000 1.94%

% of portfolio

0.12%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$190.52 - $236.72 $14,289 - $17,754	-75 Reduced 5.2%	1,366 $316,000
Q1 2024 Apr 23, 2024	SELL	$212.02 - $267.71 $22,262 - $28,109	-105 Reduced 6.79%	1,441 $310,000
Q1 2023 Apr 17, 2023	BUY	$256.56 - $292.34 $2,565 - $2,923	10 Added 0.65%	1,546 $429,000
Q4 2022 Feb 01, 2023	BUY	$252.44 - $306.72 $21,457 - $26,071	85 Added 5.86%	1,536 $425,000
Q3 2022 Oct 12, 2022	SELL	$194.69 - $268.46 $21,026 - $28,993	-108 Reduced 6.93%	1,451 $387,000
Q2 2022 Jul 20, 2022	BUY	$187.54 - $223.02 $1,875 - $2,230	10 Added 0.65%	1,559 $318,000
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $2,906 - $3,662	15 Added 0.98%	1,549 $326,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $38,066 - $48,920	-170 Reduced 9.98%	1,534 $368,000
Q2 2021 Jul 23, 2021	BUY	$259.0 - $414.71 $29,785 - $47,691	115 Added 7.24%	1,704 $590,000
Q1 2021 Apr 22, 2021	BUY	$242.95 - $284.63 $15,791 - $18,500	65 Added 4.27%	1,589 $445,000
Q4 2020 Feb 01, 2021	SELL	$236.26 - $355.63 $35,675 - $53,700	-151 Reduced 9.01%	1,524 $373,000
Q3 2020 Oct 14, 2020	SELL	$264.77 - $305.71 $6,619 - $7,642	-25 Reduced 1.47%	1,675 $475,000
Q2 2020 Jul 24, 2020	BUY	$258.66 - $342.55 $11,639 - $15,414	45 Added 2.72%	1,700 $455,000
Q1 2020 Apr 16, 2020	BUY	$268.85 - $341.04 $8,065 - $10,231	30 Added 1.85%	1,655 $524,000
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $12,543 - $17,331	-57 Reduced 3.39%	1,625 $482,000
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $95,673 - $107,307	-440 Reduced 20.74%	1,682 $392,000
Q2 2019 Jul 22, 2019	BUY	$219.29 - $241.72 $4,605 - $5,076	21 Added 1.0%	2,122 $496,000
Q1 2019 Apr 19, 2019	SELL	$216.71 - $338.96 $45,509 - $71,181	-210 Reduced 9.09%	2,101 $496,000
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $52,079 - $65,964	187 Added 8.8%	2,311 $695,000
Q3 2018 Oct 26, 2018	BUY	$293.51 - $383.83 $11,153 - $14,585	38 Added 1.82%	2,124 $750,000
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $11,845 - $14,117	-46 Reduced 2.16%	2,086 $605,000
Q1 2018 Apr 25, 2018	BUY	$260.13 - $367.91 $37,978 - $53,714	146 Added 7.35%	2,132 $583,000
Q4 2017 Apr 05, 2018	BUY	$307.64 - $344.58 $610,973 - $684,335	1,986	1,986 $632,000

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.

Account

Cornell Pochily Investment Advisors, Inc. Biogen Inc. Transaction History